{"id":"https://openalex.org/W4392689250","doi":"https://doi.org/10.1158/1541-7786.c.6540643","title":"Data from Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma","display_name":"Data from Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392689250","doi":"https://doi.org/10.1158/1541-7786.c.6540643"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.c.6540643","doi":"https://doi.org/10.1158/1541-7786.c.6540643","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6540643","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1541-7786.c.6540643","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059504042","display_name":"Carlos Rodrigo Gil del Alcazar","orcid":"https://orcid.org/0000-0002-7167-1069","observed_orcids":["https://orcid.org/0000-0002-7167-1069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Rodrigo Gil del Alcazar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046318231","display_name":"Pavlina Krasimirova Todorova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pavlina Krasimirova Todorova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014124937","display_name":"Amyn A. Habib","orcid":"https://orcid.org/0000-0003-4164-9028","observed_orcids":["https://orcid.org/0000-0003-4164-9028"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amyn A. Habib","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Bipasha Mukherjee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bipasha Mukherjee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069837318","display_name":"Sandeep Burma","orcid":"https://orcid.org/0000-0001-7057-9845","observed_orcids":["https://orcid.org/0000-0001-7057-9845"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandeep Burma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.11490000039339066,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/temozolomide-resistance","display_name":"temozolomide resistance","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6579999923706055},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9380000233650208},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.9869999885559082},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.8180000185966492},{"id":"https://openalex.org/keywords/rad51-foci","display_name":"RAD51 foci","score":0.7639999985694885},{"id":"https://openalex.org/keywords/sister-chromatid-exchange","display_name":"sister chromatid exchange","score":0.984000027179718},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.9619246125221252},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.8367128372192383},{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.5609802007675171},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38974523544311523},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3260088264942169},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2823374271392822},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21306374669075012},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.06172439455986023}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1541-7786.c.6540643","doi":"https://doi.org/10.1158/1541-7786.c.6540643","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6540643","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.c.6540643","doi":"https://doi.org/10.1158/1541-7786.c.6540643","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6540643","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2471749589","https://openalex.org/W2604413798","https://openalex.org/W2899680675","https://openalex.org/W2900003524","https://openalex.org/W4403960800","https://openalex.org/W2887953261","https://openalex.org/W2065069443","https://openalex.org/W7116423336","https://openalex.org/W7153294156","https://openalex.org/W2954152102"],"abstract_inverted_index":{"Abstract":[0],"Glioblastoma":[1],"(GBM)":[2],"is":[3,15,23,256],"the":[4,26,65,75,99,108,119,122,129,132,138,174,187,238,269,273],"most":[5],"common":[6],"and":[7,14,37,46,93,102,209,227,244,266],"aggressive":[8],"primary":[9,100,112],"brain":[10],"tumor":[11,248],"in":[12,56,64,137,186,219,241,264],"adults":[13],"universally":[16],"fatal.":[17],"The":[18],"DNA":[19,160,166],"alkylating":[20],"agent":[21],"temozolomide":[22,80,91,136,184,262,277],"part":[24],"of":[25,42,48,59,146,150,158,205,213,221,271,284],"standard-of-care":[27],"for":[28,78],"GBM.":[29],"However,":[30],"these":[31,191,246],"tumors":[32,113,124,243],"eventually":[33],"develop":[34],"therapy-driven":[35,79],"resistance":[36,61,134,185,263],"inevitably":[38],"recur.":[39],"While":[40],"loss":[41,149],"mismatch":[43],"repair":[44,157,255],"(MMR)":[45],"re-expression":[47,145],"MGMT":[49,147],"have":[50],"been":[51],"shown":[52],"to":[53,89,116,128,135,155,182,195,250,276],"underlie":[54],"chemoresistance":[55],"a":[57,257],"fraction":[58],"GBMs,":[60],"mechanisms":[62],"operating":[63],"remaining":[66],"GBMs":[67],"are":[68,170],"not":[69,142],"well":[70],"understood.":[71],"To":[72],"better":[73],"understand":[74],"molecular":[76],"basis":[77],"resistance,":[81],"mice":[82],"bearing":[83],"orthotopic":[84],"GBM":[85],"xenografts":[86],"were":[87,96,114,125,193],"subjected":[88],"protracted":[90],"treatment,":[92],"cell":[94],"lines":[95,140],"generated":[97],"from":[98,111,121],"(untreated)":[101],"recurrent":[103,123,139,188,242],"(temozolomide-treated)":[104],"tumors.":[105],"As":[106],"expected,":[107],"cells":[109,120,192,249],"derived":[110],"sensitive":[115],"temozolomide,":[117],"whereas":[118],"significantly":[126],"resistant":[127],"drug.":[130],"Importantly,":[131],"acquired":[133,261],"was":[141,153,232],"driven":[143],"by":[144,173,278],"or":[148],"MMR":[151],"but":[152],"due":[154],"accelerated":[156],"temozolomide-induced":[159],"double-strand":[161],"breaks":[162],"(DSB).":[163],"Temozolomide":[164],"induces":[165],"replication\u2013associated":[167],"DSBs":[168],"that":[169,198,225,234],"primarily":[171],"repaired":[172],"homologous":[175],"recombination":[176],"(HR)":[177],"pathway.":[178],"Augmented":[179,253],"HR":[180,240,254,280],"appears":[181],"underpin":[183],"lines,":[189],"as":[190],"cross-resistant":[194],"other":[196],"agents":[197],"induced":[199],"replication-associated":[200],"DSBs,":[201],"exhibited":[202],"faster":[203],"resolution":[204],"damage-induced":[206],"Rad51":[207],"foci,":[208],"displayed":[210],"higher":[211],"levels":[212],"sister":[214],"chromatid":[215],"exchanges":[216],"(SCE).":[217],"Furthermore,":[218],"light":[220],"recent":[222],"studies":[223],"demonstrating":[224],"CDK1":[226],"CDK2":[228],"promote":[229],"HR,":[230],"it":[231],"found":[233],"CDK1/2":[235],"inhibitors":[236,283],"countered":[237],"heightened":[239],"sensitized":[245],"therapy-resistant":[247],"temozolomide.":[251],"Implications:":[252],"novel":[258],"mechanism":[259],"underlying":[260],"GBM,":[265],"this":[267],"raises":[268],"possibility":[270],"improving":[272],"therapeutic":[274],"response":[275],"targeting":[279],"with":[281],"small-molecule":[282],"CDK1/2.":[285],"Mol":[286],"Cancer":[287],"Res;":[288],"14(10);":[289],"928\u201340.":[290],"\u00a92016":[291],"AACR.":[292]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-13T00:00:00"}